Smoflipid and Pantoprazole sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Smoflipid (lipid injectable emulsion (soybean;mct;olive;fish)) and Pantoprazole sodium (pantoprazole sodium). Common drug interactions include nausea among females and general physical health deterioration among males.

The phase IV clinical study analyzes what interactions people have when they take Smoflipid and Pantoprazole sodium. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Smoflipid?

Smoflipid has active ingredients of lipid injectable emulsion (soybean;mct;olive;fish). eHealthMe is studying from 681 Smoflipid users. Check the latest studies of Smoflipid.

What is Pantoprazole sodium?

Pantoprazole sodium has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 66,891 Pantoprazole sodium users. Check the latest studies of Pantoprazole sodium.



On Jul, 10, 2026

14 people who take Smoflipid and Pantoprazole sodium together, and have interactions are studied.

Smoflipid and Pantoprazole sodium drug interactions.

What are the common drug interactions of Smoflipid and Pantoprazole Sodium, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Small intestinal obstruction (blockage in small intestine)
  4. Vomiting
  5. Abdominal distension
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Blood creatinine increased
  8. Blood pressure decreased
  9. Blood urea increased
  10. Body temperature increased

male:

  1. General physical health deterioration (weak health status)
  2. Haematuria (presence of blood in urine)
  3. Respiratory disorder (respiratory disease)
  4. Retroperitoneal haematoma (blood clot between the peritoneum and the posterior abdominal wall)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Urinary tract infection enterococcal
  9. Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall)
  10. Acute respiratory failure

What are the common drug interactions of Smoflipid and Pantoprazole Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Abdominal distension
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Death
  4. Hypoglycaemia (deficiency of glucose in the bloodstream)
  5. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  6. Ill-defined disorder
  7. Immunodeficiency
  8. Nausea (feeling of having an urge to vomit)
  9. Pancreatic atrophy
  10. Pyrexia (fever)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Small intestinal obstruction (blockage in small intestine)
  3. Blood creatinine increased
  4. Blood pressure decreased
  5. Blood urea increased
  6. Body temperature increased
  7. C-reactive protein increased
  8. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  9. Generalised oedema (swelling all over the body)
  10. Hypercalcaemia (elevated calcium (ca+) level in the blood)

60+:

  1. General physical health deterioration (weak health status)
  2. Haematuria (presence of blood in urine)
  3. Dyspnoea (difficult or laboured respiration)
  4. Encephalopathy (functioning of the brain is affected by some agent or condition)
  5. Large intestinal ulcer haemorrhage (bleeding from large intestine ulcer)
  6. Metastases to central nervous system (cancer spreads to central nervous system)
  7. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  8. Partial seizures (seizures which affect only a part of the brain at onset)
  9. Pelvic pain
  10. Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years)

What are the existing conditions these people have? *

  1. Diabetes: 3 people, 21.43%
  2. High Blood Pressure: 3 people, 21.43%
  3. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 14.29%
  4. Haemochromatosis (body to absorb more iron than usual from food): 2 people, 14.29%
  5. Cough: 2 people, 14.29%
  6. Fever: 2 people, 14.29%
  7. Electrolyte Imbalance: 1 person, 7.14%
  8. Indigestion: 1 person, 7.14%
  9. Hypotension (abnormally low blood pressure): 1 person, 7.14%
  10. Haemoglobin Decreased: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Smoflipid and Pantoprazole sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Smoflipid and Pantoprazole sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Smoflipid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pantoprazole sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Smoflipid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pantoprazole sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lipid injectable emulsion (soybean;mct;olive;fish) and pantoprazole sodium (the active ingredients of Smoflipid and Pantoprazole sodium, respectively), and Smoflipid and Pantoprazole sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: